ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625220 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625220; 2) Community: the network communities that were significantly associated with the response to NSC 625220; 3) Molecule: the relationships between components within communities and NSC 625220; 4) MDR: the compounds that were significantly associated with the NSC 625220.

NSC Compound Enrichment Correlation
NSC 754110 Ethyl 6-chloro-8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate 0.0195559279909782 0.13764025
NSC 102627 Yoshi 864 0.0195559279909783 -0.06355279
NSC 175630 Toyocamycin, 6-amino- 0.0195559279909783 0.20842095
NSC 191909 .alpha.-Chloro-N-(p-methoxyphenyl)succinimide 0.0195559279909783 0.17385777
NSC 3053 Actinomycin D 0.0195559279909783 -0.13979072
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0195559279909783 -0.065673872
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0195559279909783 -0.087597749
NSC 331122 Zonarol 0.0195559279909783 -0.019318025
NSC 38090 Null 0.0195559279909783 0.20491466
NSC 381866 BAFILOMYCIN DERIV. 0.0195559279909783 0.11663505
Total:42  Current:16    [First] [Prev] [Next] [Last]